Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
13.33
+0.26 (2.03%)
Sep 18, 2025, 3:17 PM EDT - Market open
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $1.95 billion as of September 18, 2025. Its market cap has decreased by -44.24% in one year.
Market Cap
1.95B
Enterprise Value
1.01B
1-Year Change
-44.24%
Ranking
Category
Stock Price
$13.33
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $1.95B, an increase of 3.38%. That is a compound annual growth rate of 0.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 1.91B | -34.81% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.32B |
| Johnson & Johnson | 426.36B |
| AbbVie | 389.77B |
| UnitedHealth Group | 307.59B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 233.10B |